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Abstract
Background Carotid endarterectomy (CEA) reduces the
risk of stroke in patients with symptomatic (>50%) and
asymptomatic (>60%) carotid artery stenosis. Here we
report the midterm results of a microsurgical non-patch
technique and compare these findings to those in the
literature.
Methods From 1998 to 2009 we treated 586 consecutive
patients with CEA. CEA was performed, under general
anesthesia, with a surgical microscope using a non-patch
technique. Somatosensory evoked potential and transcranial
Doppler were continuously monitored. Cross-clamping was
performed under EEG burst suppression and adaptive blood
pressure increase. Follow-up was performed by an inde-
pendent neurologist. Mortality at 30 days and morbidity
such as major and minor stroke, peripheral nerve palsy,
hematoma and cardiac complications were recorded. The
restenosis rate was assessed using duplex sonography 1
year after surgery.
Results A total of 439 (75%) patients had symptomatic and
147 (25%) asymptomatic stenosis; 49.7% of the stenoses
were on the right-side. Major perioperative strokes occurred
in five (0.9%) patients [n=4 (0.9%) symptomatic; n=1
(0.7%) asymptomatic patients]. Minor stroke was recorded
in six (1%) patients [n=4 (0.9%) symptomatic; n=2 (1.3%)
asymptomatic patients]. Two patients with symptomatic
stenoses died within 1 month after surgery. Nine patients
(1.5%) had reversible peripheral nerve palsies, and nine
patients (1.5%) suffered a perioperative myocardial infarc-
tion. High-grade (>70%) restenosis at 1 year was observed
in 19 (3.2%) patients [n=12 (2.7%) symptomatic; n=7
(4.7%) asymptomatic patients].
Conclusions The midterm rate of restenosis was low when
using a microscope-assisted non-patch endarterectomy tech-
nique. The 30-day morbidity and mortality rate was compa-
rable or lower than those in recently published surgical series.
Keywords Carotid Stenosis.Asymptomatic.
Symptomatic.Microsurgical.Non-patch.Restenosis
Introduction
The aim of treating patients with symptomatic or asymptom-
atic, middle- to high-grade stenoses of the internal carotid
artery (ICA) is to reduce the risk of thromboembolic events
[19, 28]. Randomized controlled trials (RCT) and meta-
analyses of individual patient data have shown that this goal
can be reached both by carotid endarterectomy (CEA) and
carotid artery stenting (CAS) [5, 11, 18, 26]. However, there
are categories of patients that seem to benefit more from
either CEA or CAS [11]; current ongoing trials aim to
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treatment is the prevention of thromboembolic events, rates
of restenosis are an important surrogate marker for recurrent
events [14]. In general, restenosis rates are lower in patients
after CEA than CAS [9, 21].
Carotid endarterectomy is one of the most thoroughly
investigated surgical and neurosurgical procedures. Techni-
ques and results of CEA have evolved over the last decades,
partly as a result of the rapidly progressing and challenging
endovascular techniques. The superiority of CEA compared
with best medical treatment in symptomatic carotid disease is
clearly established as long as surgical procedures can be
performed with morbidity and mortality rates of less than 6%
[6]. Therefore, it is mandatory to analyze institutional results
for safety and quality reasons as well as for comparison with
published results of RCTs designed to evaluate CEA and
CAS. Recently published series have reported lower rates of
perioperative stroke and death both for CEA and CAS. In the
face of this evolution, analysis of the rate of restenosis also
among surgical series is increasingly important.
We therefore prospectively collected dataonrestenosisand
outcome of all patients who underwent CEA at our neurosur-
gery department from May 1998 to December 2009.
Materials and methods
Patient selection
All patients scheduled for CEA because of symptomatic
(≥50%) or asymptomatic (≥70%) carotid artery stenosis
from May 1998 to December 2009 were prospectively
assessed at the Department of Neurosurgery, Bern University
Hospital, Bern, Switzerland. Admission of patients and
preoperative assessment was performed by the Stroke Unit
team of the Department of Neurology, Bern University
Hospital, Bern, Switzerland. Patients who were considered
symptomatic were those with a new ischemic neurological
deficit (transient or permanent) corresponding to lesions
identified by diffusion-weighted MRI.
The degree of stenosis was measured according to the
North American Symptomatic Carotid Endarterectomy
(NASCET) criteria by Doppler/duplex sonography, and
magnetic resonance angiography (MRA) or computed
tomography angiography (CTA). The percentage of steno-
sis was calculated using the formula: 100 × [1 - (minimal
residual lumen/distal lumen)] [36]. Baseline characteristics
such as age, sex, neurological and cardiovascular history as
well as vascular risk factors (arterial hypertension, smok-
ing, diabetes mellitus, obesity, positive family history and
hyperlipidemia) were collected prior to treatment. This
prospective study was approved by the ethics committee of
the Canton of Bern, Switzerland (KEK 30/02).
Surgery
S u r g e r yw a sp e r f o r m e db yt h r e es u r g e o n s( A . B . ,L . M .
and M.R.). Patients were placed under general anesthe-
sia. Neuromonitoring was achieved using intraoperative
transcranial Doppler (TCD) and somatosensory evoked
potentials (SSEP). Before cross-clamping, a burst-
suppression EEG pattern was initiated by propofol
(AstraZeneca, London, UK) administration. Intravenous
heparin (100 U/kg) (Drosspharm Ltd., Basel, Switzerland)
was administered prior to exposing the ICA. Patients
were treated with anti-platelet agents such as acetyl
salicylic acid (ASA;Bayer, Leverkusen, Germany), clo-
pidogrel (Sanofi-Aventis, Paris, France) or both. Patients
treated with warfarin were reverted and also received
intravenous heparin. Cross-clamping was initiated on the
ICA then the common carotid, external carotid and
superior thyroid artery. If the mean TCD flow velocity
dropped below 50% of the pre-clamping values and
could not be restored by increasing blood pressure, or
alternatively if SSEP deteriorated, an intraoperative
shunt (Integra Lifesciences, Plainsboro, NJ, USA) was
inserted. Before the actual endarterectomy, we inserted
the shunt after placing a longitudinal incision below and
above the plaque. This procedure was followed by a
backflow rinse of the ICA. The initial thromboendarter-
ectomy was performed using surgical loupes; the vessel
lumen was inspected, cleaned and the arterectomy
vessel’s edges sharpened. The thromboendarterectomy
was completed under a neurosurgical microscope (Zeiss,
Feldbach, Switzerland), and the arteriotomy was closed
with a continuous 6–0 monofilament suture (Tyco
Healthcare Switzerland Ltd., Wollerau, Switzerland)
(Fig. 1). In patients where the distal plaque in the ICA
could not be completely or smoothly removed, tacking
sutures (6–0 polypropylene sutures, Covidien plc, Dublin,
Fig. 1 Intraoperative situs of endarterectomy. The common carotid
artery (CC) is cross-clamped. Vascular incision goes from the CC to
the internal carotid artery (IC). External carotid artery (EC) cross-
clamped using the vessel loop. Plaque (P) is removed and the vessel
cleaned under the microscope. The vessel is closed with a 6–0 suture
424 Acta Neurochir (2012) 154:423–431Ireland) were applied. The arteriotomy was closed after
reopening the external carotid artery. Thereafter, the clamp
on the common carotid artery was released, followed by
removal of the clip on the ICA 30 s later. Flow was
controlled with a small microdoppler probe (Mizuho
Medical Inc., Tokyo, Japan). Hemostatic foam (Nycomed
Pharma AG, Dübendorf, Switzerland) was adapted to the
arteriotomy. A wound drainage was routinely placed.
Closure of the wound was performed only after stopping
any visual bleeding using bipolar coagulation and appli-
cation of a 40°C saline imbued gauze. If diffuse bleeding
could not be stopped, half of the infused heparin was
antagonized with protamine (Meda Pharmaceuticals,
Wangen-Brüttisellen, Switzerland). Six hours after sur-
gery, 300 mg ASA was administered intravenously,
followed by oral administration of 100 to 300 mg ASA
daily. In patients who were preoperatively on clopidogrel
with or without ASA for cardiac reasons, therapy was
resumed 1 day after the operation.
Follow-up
Follow-up was performed by an independent neurologist. All
neurological and non-neurological complications after CEA
were assessed. Vessel patency and rate of restenosis were
assessed based on color-coded duplex sonographic findings
immediately after the operation and several time points
postoperatively: 5 days, 6 weeks and 1 year. Secondary
prevention was achieved with administration of ASA or
clopidogreleachday. Astatinwas prescribedinselectpatients
by the treating neurologist until 2006 and to all patients after
the publication of the Stroke Prevention by Aggressive
Reduction in Cholesterol Levels (SPARCL) study [2]. For
classifying the restenosis rate, a postoperative ultrasound 1
year after surgery was performed. In cases of suspected
restenosis, either a MRI or CTA was performed.
Death
Patients who died within 30 days after surgery were
included in the database and classified as death related to
surgery unless another cause was identified. Death from
stroke related to a restenosis during the follow-up was
recorded as well.
Postoperative stroke definitions
Major stroke was defined as a new neurological deficit
lasting more than 3 days or until the clinical follow-up
examination performed 30 days after surgery. Minor stroke
was defined as a new neurological deficit resolving within 3
days, without causing any transient independency, occur-
ring within 30 days after surgery.
Combined morbidity and mortality
The combined morbidity and mortality rate was defined as
all deaths and neurological sequelae, including minor and
major strokes, due to the operated carotid artery. Peripheral
nerve palsies were assessed separately.
Hematoma
Postoperative hematoma was defined as a swelling due to a
local cervical hematoma necessitating a second surgical
intervention. Clinically non-relevant postoperative swelling
was not recorded.
Peripheral nerve palsy
A peripheral nerve palsy was recorded if a new postoper-
ative palsy for tongue pulling, swallowing or hoarseness
was observed (hypoglossal nerve, vagal nerve or ansa
cervicalis) and persisted more than 30 days.
Non-neurological complications
Complications other than those mentioned above, such as
myocardial infarction (non-ST elevation and ST elevation),
were recorded.
Restenosis
Restenosis was assessed 1 year after surgery by color-coded
duplex sonography. Restenosis was considered high-grade if
peak systolic velocity exceeded 200 cm/s. Moderate stenosis
was diagnosed if peak systolic velocity exceeded 120 cm/s. If
an increase in the degree of stenosis was detected, additional
follow-upvisitswererequired.Asecondinterventionforearly
redo surgery or stenting was considered only if patients were
symptomatic or had stenosis over 70%.
Statistics
Statistical evaluations were performed using a commercial-
ly available software package (GraphPad Software, La
Jolla, CA, USA). Data are presented as the mean and
standard deviation. Groups were compared using Fisher’s
exact test. Significance was set at a p value of 0.05.
Results
Demographics
From 1998 to 2009, 586 consecutive patients (70% men;
mean age 69.4±8.8 years) were treated with microsurgical
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was 69.6±8.8 years, while the age in asymptomatic patients
was 68.8±8.5 years (Table 1). Right- and left-sided
stenoses were equally distributed (49.7% right, 50.3% left).
Four hundred thirty-nine (75%) patients had symptomatic
and 147 (25%) asymptomatic stenosis. We had a propor-
tionally higher number of symptomatic patients in our
series compared to other series, especially vascular. This
can be explained by the standard referral practice used in
our hospital, which refers all symptomatic stenosis patients
to the neurology department and thereafter to the neurosur-
gery department, while asymptomatic patients are rather
referred directly to vascular surgeons. As a result of this
referral practice, the number of symptomatic patients
operated on by neurosurgeons is higher.
Four hundred thirty-seven patients with a symptom-
atic high-grade stenosis completed the 6-week follow-up
examination, 397 were seen after 1 year at our
institution, and the remaining 40 patients were followed
up with duplex sonography in another facility or lost to
follow-up. Two patients died within 30 days after
surgery. Patients with duplex sonography performed in
another hospital were not included into the 1-year
follow-up. All 147 patients with asymptomatic high-
grade stenosis completed the 6-week clinical follow-up.
One hundred thirty-seven patients were seen after 1
year, and the remaining ten patients were either
followed up in another facility or lost to follow-up.
Risk factors and co-morbidities
The following vascular risk factors did not differ among
patients with symptomatic or asymptomatic carotid artery
stenosis: arterial hypertension, diabetes, hypercholesterol-
emia, smoking, peripheral arterial vascular disease, obesity
and family history of stroke.
Mortality, combined mortality and morbidity
Postoperative death occurred in 2/586 patients (0.34%).
Both patients had suffered from a symptomatic carotid
stenosis. In one patient there was a fatal intracerebral
hemorrhage 72 h (h) after intravenous thrombolysis for
middle cerebral artery infarction on the left side and 24 h
after CEA. The second fatality was due to a cardiac arrest
on postoperative day 2; no autopsy was performed.
The combined mortality and morbidity rate in all patients
was 2.2% (13/586), 2.2% (10/439) in symptomatic and
2.0% (3/147) in asymptomatic patients.
Major and minor stroke
Major stroke within 30 days occurred in 5/586 patients
(0.85%). Four of these patients (0.9%) were operated on for
symptomatic and one patient (0.7%) for asymptomatic
high-grade stenosis. Minor stroke within 30 days occurred
in six cases (1%); four of these patients had high-grade
symptomatic stenosis (Table 2).
Peripheral nerve palsies
Peripheral nerve palsy was observed in 1.53% (9/586) of
patients. These deficits resolved rapidly in most of the
patients. At 1 year follow-up all patients had normal
function of the cranial nerves.
Non-neurological complications
Overall 14 non-neurological complications were observed.
Three patients had myocardial infarctions (MI) (n=2, non-
ST elevation MI; n=1, ST elevation MI), five had angina
pectoris, and two had postoperative local infections that
were treated with intravenous antibiotics. Additionally,
there were two patients with hematomas that required
reoperation, one patient with postoperative seizure and one
with a newly diagnosed myasthenia gravis
Occlusions
Intraoperative occlusion of the carotid artery during surgery
was performed in five (0.8%) patients because of preoper-
ative occlusion and the impossibility of recanalization, and
distal extension of the plaques and impossibility of
successful recanalization. Three patients were symptomatic
and two patients asymptomatic. In addition, one patient had
postoperative blood pressure-dependent transient ischemic
attacks (TIA), which resolved and did not recur after
30 days.
Table 1 Mean age of symptomatic and asymptomatic men and women
Overall age (mean±years) Male age (mean±years) Female age (mean±years) Total n (%)
Symptomatic and asymptomatic patients 69.9±8.8 69.0±8.8 70.4±8.9 586 (100%)
Symptomatic 69.7±8.8 69.2±8.9 70.6±9.5 439 (75%)
Asymptomatic 68.8±8.5 68.5±8.4 69.6±7.1 147 (25%)
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High-grade restenosis of more than 70% occurred in 3.6%
(19/534) of the patients after CEA: 3.0% (12/439) in
symptomatic and 4.7% (7/147) in asymptomatic patients.
Moderate-grade stenosis of 50 to 70% was observed in
1.2% (7/534) of patients; these seven patients were all
symptomatic patients (Table 2, Fig. 2). Of all high- and
moderate-grade restenoses, 1.1% (5/439) had symptomatic
restenosis, all occurring in the preoperative symptomatic
group. Stenting for high-grade restenosis was performed in
1.36% (8/586) of patients: 0.9% (4/439) in symptomatic
and 2.7% (4/147) in asymptomatic patients. In one patient
(0.2%) with symptomatic carotid artery stenosis reendarter-
ectomy was performed. Restenosis rates did not differ
between the pre- and post-statin era; however, the number
of patients with restenosis was low in both asymptomatic
(0/7) and symptomatic (2/81) patients.
Intraoperative shunt rate
In 11% of all operations, intraoperative shunting was used.
The rate of intraoperative shunt placement in patients
suffering postoperative minor or major stroke was 23%;
however thromboembolic complications were not signifi-
cantly more common (p=0.112) when compared to all
operated patients.
Discussion
The NASCET found an absolute risk reduction of ipsilat-
eral stroke of 17% at 2 years in patients with stenosis higher
than 70% [28]. Since then, endarterectomy has been
recommended for patients with high-grade stenosis. In
1991, the European Carotid Surgery Trial (ECST) demon-
strated a significant reduction of the overall stroke risk in
operated patients with symptomatic high-grade stenosis
(70–99% according to the ECST criteria) compared with
best medical treatment [19]. The perioperative risks of
stroke and death within 30 days of CEA were 6.8% (95%
CI: 5.6–8.0) in the ECST and 6.7% (95% CI: 5.3–8.4%) in
the NASCET populations. These risk rates were higher than
those reported in many surgical case series as outlined
below. The operative risk in the ECST was significantly
higher in women (p<0.0001), although this difference was
not seen in the NASCET.
Since these two large multicenter trials demonstrated the
benefit of CEA over best medical treatment, two clinically
relevant factors have changed, leading to many new RCTs.
Firstly CAS has been introduced and equipoise to CEA,
defined in specific clinical circumstances. Second, best
medical treatment was reinforced with statins [2], thereby
rendering the risk of stroke lower than the stroke risk
reduction found in NASCET and ECST. Nevertheless, the
data of the NASCET and the ECST trial remain the best
available for treatment of carotid artery disease. In the
Carotid Revascularization Endarterectomy versus Stenting
Trial (CREST), the combined rate of stroke and death was
Table 2 Rate of major/minor stroke and restenosis rate in symptomatic and asymptomatic carotid stenosis
Overall % (n) (N=586) Symptomatic % (n) (N=439) Asymptomatic % (n) (N=147)
Minor stroke 1.02% (5) 0.9% (4) 1.4% (2)
Major stroke 0.85% (5) 0.9% (4) 0.7% (1)
Restenosis (≥70%) 3.2% (19) 2.7% (12) 4.7% (7)
Restenosis (≤69%) 1.2% (7) 1.6% (7) 0% (0)
Fig. 2 a Kaplan-Meier curve: Free of restenosis (high and low grade
restenosis) over time in patients with symptomatic stenosis (in red)
and in patients with asymptomatic stenosis (blue). b Bars show the
absolute numbers of restenosis overall in symptomatic and asymp-
tomatic patients differentiated for high and low grade stenosis.
Numbers show the percent of each group
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patients with carotid stenosis having undergone CEA [25].
In a US nationwide inpatient study that included 482,394
patients having undergone CEA, the combined stroke and
death rate was reported as 0.9% in the asymptomatic and
5.9% in the symptomatic group overall in high-risk and low-
risk patients [20]. A meta-analysis of short-term and long-
term outcomes of CAS and CEA trials reported a similar
range of rates for stroke and death as previously mentioned
[17]. Specifically the rates of periprocedural stroke and death
were in favor of CEA compared to CAS.
Over the last decades, the CEA procedure has been
constantly critically reviewed in many studies, leading to
improvement and standardization. CREST has given us
new trends toward the choice of indication for CEA or
CAS. However, the question of restenosis is often not taken
into account in these studies. Overall, various factors such
as usage of surgical microscopes, patch techniques, anes-
thesia, neuromonitoring, intraoperative shunting and most
importantly standardized screening procedures have led to a
reduction of mortality and morbidity [13, 31, 32, 37].
Preoperative evaluation
Carotid artery stenosis is diagnosed by using color-coded
duplex sonography to determine the degree of stenosis.
This method also allows accurate assessment of plaque
morphology. The exam is completed with TCD sonography
of the circle of Willis and the vertebral arteries to assess the
flow velocities, the direction of flow and the significance of
a collateralization over the anterior and posterior commu-
nicating arteries. Intraoperative knowledge about collateral
flow lowers the probability of the necessity to place an
intraoperative temporary shunt, which is associated with an
increased risk of embolism during placement and should
thus only be performed when necessary [29, 30, 33].
At our institution, the diagnosis is always confirmed with a
second imaging modality, either MRA or CTA. In addition,
when determining the anatomical location and extent of the
stenosis, MRA allows the visualization of past and present
cerebral ischemic areas. This is important in cases of
symptomatic carotid artery stenosis with large diffusion-
restricted areas since the risk of post-endarterectomy hemor-
rhagic transformation is increased in these patients [3, 16],
especially after intravenous thrombolysis [7]. The previously
accepted notion that CEA should be delayed 4 to 6 weeks
after stroke is challenged by more recent evidence suggesting
that CEA can be safely performed earlier in clinically stable
patients who have mild to moderate deficits. This is
especially true for patients who have a TIA or minor stroke
without or only with minimal imaging evidence of infarction
or mass effect, and a stable deficit where there is no reason to
empirically delay carotid endarterectomy [4].
Restenosis
As the reported perioperative risks for the treatment of
carotid artery stenosis both for CEA and CAS are lower, the
rate of restenosis is increasingly more important. Two to
12% of patients with treated carotid stenosis have recurrent
cerebrovascular events due to a high-grade restenosis in
CAS as well as CEA [14, 21]. Although CEA has overall a
lower rate of restenosis rate than CAS [9, 18], the rates of
restenosis of surgical series using different operative
techniques also have to be reported. The addition of statins
to the medical therapy has without doubt reduced the
overall recurrence of restenosis [2].
The two techniques used in our series, in comparison to
other surgical series, were the use of a neurosurgical
microscope, resulting in thorough vessel cleaning, and
minimal conserving running suture and the waiver of any
additional patch. In the literature there are no data
supporting the advantages of the use of a microscope over
surgical loupes for CEA. Neurosurgeons tend to use the
microscope more often than vascular surgeons. The
microscope has one advantage over the loupes in that it
enables a higher magnification with perfect coaxial illumi-
nation. Therefore, a thorough cleaning of the vessel lumen
is possible even with microinstruments. Furthermore, the
overlay of the running suture for the vessel closure can be
kept at a minimum, resulting in no constriction and
practically restoring the original size of the vessel. Guzman
et al. demonstrated that intraoperatively assessed dimen-
sions of the carotid artery (common, external and internal)
after removal of stenosis corresponded to the postoperative
3D-MRA findings that showed an anatomical normalization
of the vessel structure [22]. This might be a reason why our
results are comparable to other series using a routine
patching technique [12, 38].
Recent literature on patching, however, reports a lower
restenosis rate when using polytetrafluoroethylene (PTFE)
patches, revealing a superiority over Dacron or saphenous
vein grafts [1, 10, 12, 32]. In a prospective randomized
trial, 1 year restenosis was favorable for Gore-Tex versus
Hemashield patching (2% versus 8%, respectively) [1]. In
2005, Bart et al. reported a worsening restenosis rate
400 days after CEAwhen comparing venous patch, primary
closure and Dacron patch (7%, 11% and 16%, respective-
ly). Byrne et al. reviewed the literature in 2007 comparing
primary versus venous patching, and venous versus Dacron
patching. Dacron patching performed the worst in all
studies, and primary was more often worse than venous
patching, leading to the conclusion that venous patching
appeared to perform superiorly to primary closure [12].
Regarding this evidence, perhaps a new policy with routine
use of a roof PTFE patch angioplasty might further improve
the restenosis rate in the future. However, a slight increase
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[35]. Less postoperative hemorrhage has been reported
when using a pericard patch; in addition, restenosis with a
pericard patch has been reported between 2% to 7% [23,
24, 27]. Based on our midterm analysis of restenosis from
this series and the reported literature, we conclude that it is
essential to continue with primary closure using a micro-
surgical technique. In our series, a patch enlargement did
not seem necessary. However, this will need to be
confirmed by long-term analysis.
Intraoperative shunt
In our series we did not find a significantly higher rate of
postoperative neurological deficits related to intraoperative
shunting; however, there was an observable increase in
neurological deficits in this group of patients. Although the
shunt was immediately placed after opening the vessel
below and above the plaque and the backflow of the opened
ICA rinsed the vessel, it can be hypothesized that a small
amount of debris from the remaining plaque embolized and
was responsible for the neurological deficits. Given that we
had a higher number of symptomatic patients, an adaptation
to our surgical routine may require placing the shunt only
after cleaning the internal carotid artery under the micro-
scope or only when the SSEP begins to lower.
Local anesthesia/general anesthesia
A recent Cochrane review compared local versus general
anesthesia, where patients and surgeons could choose either
anesthetic technique depending on the clinical situation and
preferences [31]. It is difficult to ascertain the clinical
differences of local anesthesia over general anesthesia.
Overall, we can assume that general anesthesia remains the
most common practice across all specialties performing
CEA. A systematic protocol for the different steps in the
endarterectomy procedure is important for the success and
reduction of morbidity. Furthermore, the type of anesthesia is
also dependent on the clinical condition of the patient.
Monitoring
Thereareamultitudeofdifferentintraoperativetechniquesfor
evaluating the necessity for an intraoperative shunt, a topic
still much debated in the literature. However, in our study, the
stroke risk of distal embolization tended to be higher in
shunted than in non-shunted patients, although this was not
statistically significant. Visual assessment of back bleeding
from the ICA is probably the easiest method for subjective
assessment of intracranial collateralization, but at the same
time probably also the least significant. Measuring the stump
pressuremay bemoreobjective,but the literaturegives values
for a cutoff between 25 to 70 mmHg. Despite stump pressures
greater than 50 mmHg, up to 9% of patients lost conscious-
ness and required a temporary shunt in two series of CEA
performed under local and general anesthesia [8, 34]. Trans-
cranial Doppler ultrasound is gaining increasing importance
for a variety of reasons: first, it gives an objective value of
flow velocities that leads to the decision to insert a temporary
shunt. Second, the increase of arterial blood pressure during
cross-clamping can be directly monitored, in addition to
monitoring the correct functioning of a temporary shunt.
Although SSEP monitoring is slower in response than TCD,
it gives additional security and information, especially when
TCD is not possible. The combination of TCD and SSEP
monitoring in the setup of general anesthesia with routine
burst suppression and adaptive blood pressure control after
cross-clamping in our series led to good results also in
comparison with the literature. We insert a temporary shunt if
pre-cross-clamping TCD flow velocities fall to 50% and a
sufficient increase in blood pressure cannot be achieved.
In our series we found non-significantly higher rates of
postoperative complications in shunted patients. There are
two aspects of this issue to be considered: either there is an
inherent higher risk of complications using a shunt or the
complication rate is higher because it is not routinely used.
This can only be answered by a randomized trial with a
long-term follow-up (over several years) [33].
Indication for intervention (CEA or CAS)
The recent literature reports that morbidity and mortality need
to be lower than 6% in order to perform a CEA, and CAS
shouldalsoachievethesamerates.Itisthereforemandatoryto
assess results derived from local centers for both CEA and
CAS. The recently published results of the CREST study
further support a selection of treatment methods according to
patientageandpresenceofsymptoms[11]. The findings from
our study support the use of CEA both for symptomatic and
asymptomatic carotid stenosis using our technical and
anesthesiology procedures. The data analysis however does
not allow any further specification according to patient age
or sex. Furthermore, our study was designed to ascertain the
rate of restenosis and the outcome.
Conclusion
Carotid endarterectomy is a safe procedure with an overall
low morbidity and mortality in patients with symptomatic
and asymptomatic carotid stenosis. Microsurgical techni-
ques using a neurosurgical microscope without patching
resulted in a low midterm restenosis rate compared to other
surgical series in the literature, especially using patching
techniques.
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Comment
Carotid endarterectomy still represents a valuable technique in the
prevention of major neurologic ischemic events in patients with
significant carotid stenosis. The different techniques used for
carotid artery closure after this procedure aim to guarantee low
restenosis rates, both in terms of early and long-term results.
Patch closure has been considered an optimal solution in order to
reduce the risk of restenosis related to technical inaccuracies
during carotid artery closure. The use of a microsurgical non-
patch technique for primary closure compared to the standard
primary closure has the appeal of eliminating those technical
inadequacies in the suture line; the excellent mid-term results
obtained in this series confirm this hypothesis. However, it is
important to remember that restenosis could be also and maybe
primarily related to miointimal hyperplasia or thrombotic apposi-
tion in the endarterectomized carotid wall. Both these events have
a long time progression, and restenosis could be identified many
years after the procedure. It will be really interesting to have a
description of the results presented here in the future for the
evaluation of long-term restenosis rates after using the micro-
surgical non-patch technique. Another important issue is related to
the learning curve needed for this procedure. Neurosurgeons are
used to microsurgical procedures, and this represents a great
advantage when compared to other specialties involved in the
treatment of carotid stenosis, as vascular surgeons are. If
microsurgical primary closure demonstrates comparable long-term
results to patch closure in terms of reduced restenosis rate,
microsurgical techniques should be included in vascular surgery
training programs.
Domenico d'Avella
Franco Grego
Padova, Italy
The authors here report an institutional series of 586 CEA
procedures by three surgeons over 11 years. Follow-up compliance
for 1-year ultrasonography was reasonable at about 90%. Surgical skill
and technique were excellent, as were the clinical results. The
discussion of material issues regarding stent versus CEA and the
nuances of the technique is erudite and pertinent.
The main point of this manuscript is to show that microsur-
gical repair of carotid arteriotomy yields a high-grade restenosis
rate of 3.6% at 1 year. This is confounded a bit by the 90%
follow-up rate rather than perfect data. However, the conclusion
has validity; microsurgical repair with modern techniques yields
excellent results.
As I have published many times (1), my preference is for
collagen-impregnated Dacron patch repair in every case, no
microscope. The high-grade restenosis rate has not yet been
published by me, but, simply stated, it is zero at all evaluation
time points, many beyond 1 year. So while I accept that these
authors are superb technicians—I believe that they have done as
well as can possibly be done without patch grafting—yet they
still have an honest and valid figure of 3.6% recurrent high-grade
stenosis. In my heart, I beleive we can still do better, and in my
practice, universal patch grafting is the answer.
I have published many times and completely respect that many
techniques can produce good outcomes in CEA. My technique
works well for me, and I stand by it. This group shows fine
results with a different technique, and I applaud them for their
excellent contribution.
Christopher M. Loftus
Philadelphia, PA
1. Loftus CM: Carotid Artery Surgery: Principles and Technique.
2nd edition. New York, Informa Publishing 2006.
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